C.M. Bidwell & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-136
| Closed | -$12.2K | – | 519 |
|
|
2024
Q3 | $12.2K | Buy |
136
+45
| +49% | +$3.79K | 0.01% | 275 |
|
|
2024
Q2 | $7.16K | Hold |
91
| – | – | ﹤0.01% | 301 |
|
|
2024
Q1 | $7.93K | Hold |
91
| – | – | 0.01% | 297 |
|
|
2023
Q4 | $7.5K | Hold |
91
| – | – | 0.01% | 308 |
|
|
2023
Q3 | $7.13K | Hold |
91
| – | – | 0.01% | 374 |
|
|
2023
Q2 | $8.02K | Hold |
91
| – | – | 0.01% | 378 |
|
|
2023
Q1 | $7.34K | Hold |
91
| – | – | 0.01% | 378 |
|
|
2022
Q4 | $7.07K | Hold |
91
| – | – | 0.01% | 370 |
|
|
2022
Q3 | $7K | Hold |
91
| – | – | 0.01% | 371 |
|
|
2022
Q2 | $8K | Hold |
91
| – | – | 0.01% | 356 |
|
|
2022
Q1 | $10K | Hold |
91
| – | – | 0.01% | 367 |
|
|
2021
Q4 | $9K | Hold |
91
| – | – | 0.01% | 393 |
|
|
2021
Q3 | $11K | Hold |
91
| – | – | 0.01% | 388 |
|
|
2021
Q2 | $11K | Hold |
91
| – | – | 0.01% | 390 |
|
|
2021
Q1 | $11K | Buy |
+91
| New | +$10.7K | 0.01% | 384 |
|
|
2020
Q1 | – | Sell |
-5,580
| Closed | -$633K | – | 417 |
|
|
2019
Q4 | $633K | Buy |
5,580
+3,690
| +195% | +$405K | 0.57% | 36 |
|
|
2019
Q3 | $205K | Buy |
+1,890
| New | +$197K | 0.2% | 128 |
|
|
2017
Q3 | – | Sell |
-2,290
| Closed | -$203K | – | 346 |
|
|
2017
Q2 | $203K | Sell |
2,290
-49,345
| -96% | -$4.16M | 0.04% | 148 |
|
|
2017
Q1 | $4.16M | Buy |
+51,635
| New | +$4.03M | 0.94% | 41 |
|
|
2016
Q3 | – | Sell |
-3,265
| Closed | -$283K | – | 295 |
|
|
2016
Q2 | $283K | Hold |
3,265
| – | – | 0.07% | 127 |
|
|
2016
Q1 | $245K | Buy |
+3,265
| New | +$246K | 0.06% | 148 |
|
|
2015
Q2 | – | Sell |
-4,210
| Closed | -$328K | – | 247 |
|
|
2015
Q1 | $328K | Buy |
+4,210
| New | +$319K | 0.07% | 117 |
|
|
2014
Q3 | – | Sell |
-160
| Closed | -$10K | – | 268 |
|
|
2014
Q2 | $10K | Sell |
160
-855
| -84% | -$51.9K | ﹤0.01% | 222 |
|
|
2014
Q1 | $62K | Sell |
1,015
-65
| -6% | -$3.79K | 0.01% | 200 |
|
|
2013
Q4 | $62K | Sell |
1,080
-180
| -14% | -$10.2K | 0.02% | 207 |
|
|
2013
Q3 | $67K | Hold |
1,260
| – | – | 0.02% | 207 |
|
|
2013
Q2 | $64.9K | Buy |
+1,260
| New | +$62.3K | 0.02% | 211 |
|
Other funds holding MDT
C.M. Bidwell & Associates's MDT Position: Q4 2024 in Review
C.M. Bidwell & Associates sold out of Medtronic (MDT) in Q4 2024, closing a stake of 136 shares — an estimated $12.2K sold.
C.M. Bidwell & Associates first reported a position in MDT in Q2 2013 and held it in 27 quarters. The position peaked at $4.16M in Q1 2017. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.
- C.M. Bidwell & Associates reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
- C.M. Bidwell & Associates sold 136 Medtronic shares in Q4 2024, an estimated $12.2K.
- C.M. Bidwell & Associates first reported a position in Medtronic in Q2 2013 and held it in 27 quarters.
- C.M. Bidwell & Associates's Medtronic position peaked at $4.16M in Q1 2017.
- 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.
Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.